News

Eli Lilly plans to increase prices of medicines in Europe and other developed markets “in order to make them lower” in the ...
The average short interest in the S&P 500 Health Care Index Sector (NYSEARCA:XLV) dipped slightly in July to 1.95% from 1.96% ...
While it’s been easy to grow a bit desensitized to the seemingly unstoppable sales growth of Novo Nordisk and Eli Lilly’s | ...
Pharmacists warn patients not to buy dangerous counterfeit medicines as drugmaker set to triple price of prescription ...
Instead of going to the pharmacy to get the annual flu vaccine, many people in the US will now be able to get it shipped to their door to take at home themselves. Starting today, AstraZeneca’s FluMist ...
Amid pressure from the White House, U.S. drug companies are experimenting with direct-to-consumer sales models that cut out the middlemen.
Eli Lilly announced the price hike from September following calls from President Donald Trump to increase European prices ...
This episode of Pharma Pulse discusses a new executive order to build a domestic API stockpile, Eli Lilly’s 170% price ...
Mounjaro, one of the UK’s most popular weight-loss jabs, is set to become more expensive for private patients after Eli Lilly ...
A major change to the price of Mounjaro is set to come into effect in the UK on September 1. Drug manufacturer Eli Lilly has ...
Eli Lilly said the increase brings the UK price in line with other European markets, though NHS availability will be ...